BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Leukemia, Kidney, Holistic medicine, Trichostatin A, rs6983267, PTEN)
Bookmark Forward

QuickView for Tlr9 (gene)


Body Atlas

Most Correlated Tissues

  1. Tonsil
  2. Rectum colon
  3. Ascending colon
  4. Pancreas
  5. Sigmoid colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Disease due to Flaviviridae
  2. Coronavirus infection
  3. Viral carditis
  4. Infection due to Haemophilus
  5. Disease due to Rotavirus
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. diethyl maleate
  2. Salivary Cystatins
  3. Oligodeoxyribonucleotides
  4. abatacept
  5. Acriflavine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. DPRX
  2. DDX17
  3. ABCC5
  4. EN1
  5. FOXP2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice.
  2. Toll-like receptor 9 signaling is associated with immune responses to Trypanosoma brucei infection.
  3. Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV.
  4. Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergeti…
  5. Recognition of Chlamydia trachomatis by Toll-like receptor 9 is altered during persistence.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With …
  2. TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refracto…
  3. Innate Immunity Stimulation Via TLR9 in Early AD
  4. Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
  5. CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.